Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 01 Jul 2021 for CRISPR Therapeutics AG, €3.5M. Read the official filing
Filing timeline
BuySaleRodger Novak
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Rodger Novak: trading record in brief
Rodger Novak is a declared insider of CRISPR Therapeutics AG (chief executive), with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 21 June 2021 to 30 June 2021.
Every open-market trade on record is a sale: 3 sales worth €6.9M.
The latest filing, published on 1 July 2021, reports an open-market sale of €3.5M in CRISPR Therapeutics AG. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Rodger Novak
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
25,000 shares@ US$165.0050.5% of flowCommon SharesSEC:0001209191-21-044516:0
25,000 shares@ US$156.5547.7% of flowCommon SharesSEC:0001209191-21-044012:0
1,171 shares@ US$125.581.8% of flowCommon SharesSEC:0001209191-21-042811:0
3 of 3 declarations
